About OncoDNA
OncoDNA is a company based in Charleroi (Belgium) founded in 2012.. OncoDNA has raised $44.53 million across 6 funding rounds from investors including Copenhagen Airport, Swisscanto and Ackermans & van Haaren. OncoDNA has completed 1 acquisition, including Bio Sequence. OncoDNA offers products and services including OncoDEEP Kit, OncoSELECT Kit, OncoCDI, and OncoKDM. OncoDNA operates in a competitive market with competitors including Denali Therapeutics, Inscripta, MiRagen, Poseida Therapeutics and Juno Therapeutics, among others.
- Headquarter Charleroi, Belgium
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oncodna S.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$44.53 M (USD)
in 6 rounds
-
Latest Funding Round
$127.79 K (USD), Grant
Nov 01, 2023
-
Investors
Copenhagen Airport
& 15 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OncoDNA
OncoDNA offers a comprehensive portfolio of products and services, including OncoDEEP Kit, OncoSELECT Kit, OncoCDI, and OncoKDM. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kit for comprehensive genomic profiling of tumors.
Kit for detecting biomarkers in liquid samples.
Platform for analyzing clinical data in oncology research.
Tool for interpreting genomic data in precision medicine.
Unlock access to complete
Unlock access to complete
Funding Insights of OncoDNA
OncoDNA has successfully raised a total of $44.53M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $127.79 thousand completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $127,789
-
First Round
First Round
(01 Dec 2012)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Grant - OncoDNA | Valuation |
investors |
|
| Jul, 2023 | Amount | Series C - OncoDNA | Valuation | Wallonie Entreprendre | |
| Feb, 2020 | Amount | Series B - OncoDNA | Valuation | Swisscanto , Vesalius Biocapital III |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OncoDNA
OncoDNA has secured backing from 16 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Copenhagen Airport, Swisscanto and Ackermans & van Haaren. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A European life sciences venture capital investor is operated.
|
Founded Year | Domain | Location | |
|
VC & PE fund
|
Founded Year | Domain | Location | |
|
Buyouts are pursued by SRIW as a private equity firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OncoDNA
OncoDNA has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bio Sequence. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnosis solutions for precision cancer medicine are developed.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - OncoDNA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncodna Comparisons
Competitors of OncoDNA
OncoDNA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Inscripta, MiRagen, Poseida Therapeutics and Juno Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncodna
Frequently Asked Questions about OncoDNA
When was OncoDNA founded?
OncoDNA was founded in 2012.
Where is OncoDNA located?
OncoDNA is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
Is OncoDNA a funded company?
OncoDNA is a funded company, having raised a total of $44.53M across 6 funding rounds to date. The company's 1st funding round was a Series B of $20.58M, raised on Dec 01, 2012.
What does OncoDNA do?
OncoDNA was founded in 2012 and is based in Charleroi, Belgium. Operations focus on the oncology sector, where theranostic and genomic tools support precision medicine. Biomarker tests offered include OncoDEEP for therapeutic guidance, OncoSELECT as a liquid biopsy for monitoring and treatment, and OncoFOLLOW for tracking tumor progression. An NGS interpretation platform called OncoKDM and a biomarker test platform named OncoSHARE are also provided.
Who are the top competitors of OncoDNA?
OncoDNA's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
What products or services does OncoDNA offer?
OncoDNA offers OncoDEEP Kit, OncoSELECT Kit, OncoCDI, and OncoKDM.
How many acquisitions has OncoDNA made?
OncoDNA has made 1 acquisition, including Bio Sequence.
Who are OncoDNA's investors?
OncoDNA has 16 investors. Key investors include Copenhagen Airport, Swisscanto, Ackermans & van Haaren, European Union, and SFPIM.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.